Marc's work sits at the intersection of technical depth, AI product development, and commercial strategy. He has developed and launched eight CE-marked AI-driven biomarkers for oncology, achieved FDA clearance for an AI imaging platform, and holds a US patent for AI-driven biomarker detection. He supports companies developing clinically relevant and technically demanding products, particularly where AI, evidence, product direction, and regulatory requirements need to be brought into sharp alignment. His perspective is especially valuable for businesses in healthtech, medtech, and diagnostics where scientific and AI credibility are commercial prerequisites.
Marc leads GoldWhite's life sciences and health-tech practice. He brings over a decade of experience spanning pharmaceutical R&D, AI-driven diagnostics, clinical biomarker strategy, and regulatory affairs.
As Director of Translational Sciences at a leading global pharmaceutical company, Marc leads enterprise-wide precision medicine strategies across multiple therapeutic areas, partnering with R&D, commercial, and regulatory teams to accelerate drug development. He has developed strategies for clinical trials ranging from Phase 1b to Phase 3 across immunology and fibrosis.
Prior to this, Marc was Senior Product Owner at Paige.AI in New York and London, where he launched eight CE-marked AI-driven biomarkers for oncology. At Perspectum in Oxford, he led new indications strategy and achieved FDA clearance and CE marking for MRCP+, managing a cross-functional team of twenty. He has also served as a Policy Advisor to the Cabinet Office Open Innovation Team.
Marc holds a PhD in Clinical Neuroscience from Imperial College London, where his research focused on the blood-brain barrier in chronic traumatic encephalopathy. He holds an MSc in Neuroscience from King's College London and a BA in Psychology and Behavioural Neuroscience from McGill University. He is a published researcher with work appearing in Brain, Nature Communications, the Journal of Magnetic Resonance Imaging, and Acta Neuropathologica, and is a named inventor on a US patent for AI-driven biomarker detection.
David combines technical training in engineering with experience in investment banking and financial markets. He brings a strong commercial and investor-oriented perspective to businesses that need sharper strategic framing, clearer market positioning, and greater fundraising readiness. His background is particularly relevant for technically strong companies that need to communicate more effectively with investors, partners, and stakeholders, without losing the technical credibility that makes them worth backing. He has also established scientific rationale and testing protocols for multiple non-invasive AI-driven medical devices, giving him a practical understanding of what it takes to build and validate AI products in regulated environments.
David leads GoldWhite's fundraising and commercial advisory practice. He combines an unusual depth of experience spanning academic engineering research, investment banking, derivatives trading, and startup founding to help STEM companies raise capital and build sustainable businesses.
Before founding GoldWhite, David was an equity derivatives trader at Goldman Sachs in London, structuring derivative products for the German issuance market, and an M&A analyst at Leonardo & Co. in Frankfurt, where he worked on transactions including a €500M capital raising in the transportation sector.
David has co-founded two technology companies: a technology platform that was sold privately, and Model.Me, a mobile fashion startup that raised a $1.5M seed round in New York before being acquired. He has also served as a strategy consultant at Cambridge's Institute for Manufacturing and lectured at the Judge Business School.
At GoldWhite, David has established scientific rationale and testing protocols for multiple non-invasive medical devices, managed KOL engagement, led clinical and academic project execution, and personally raised over £6M across investment rounds and grant applications for clients.
David holds a PhD in Engineering from the University of Cambridge, where his research on open innovation in high-tech SMEs received a Best Paper Award at the IEEE International Conference on Management of Innovation & Technology. He also holds an MPhil from the Judge Business School, University of Cambridge (Distinction).
Jonas thinks and works like a builder. Trained as an architect at two of Europe's most distinguished schools, he developed the ability to hold enormous complexity (technical, spatial, human, operational) and turn it into something that actually functions. That discipline translates directly into product strategy, UX and consumer pathway design, operational build-out, and the structural thinking that fast-moving startups need but rarely have. He also brings fluency in AI application to design and operational problems, including the use of generative and agentic AI tools to accelerate product development and operational workflows. Where most operators learn by doing, Jonas learned by designing systems at scale. He then built companies on top of that foundation.
Jonas leads GoldWhite's product development, operations, and execution practice. His background spans architectural design at the highest level, co-founding and operating a technology company, and hands-on advisory work with startups and growing businesses navigating operational complexity.
Trained at the Bartlett School of Architecture at UCL and Bauhaus University Weimar, Jonas developed a rigorous, systems-led approach to complexity: the ability to take a vast, multi-stakeholder challenge and design something that works at every level. That training was tested at scale on some of Europe and Asia's most demanding projects: the €200M Fontenay luxury hotel in Hamburg, a 700,000 sqft urban masterplan, and the Lodha Altamount skyscraper on Mumbai's Billionaires' Row. These were not simply design commissions. They were operational and coordination challenges of enormous complexity: managing multidisciplinary teams, intricate technical systems, demanding clients, and tight delivery constraints across multiple geographies.
Jonas co-founded a property management technology platform, where he served as COO, building the end-to-end platform, designing the user experience and consumer pathway, and managing operations through to a successful private sale. The transition from architecture to technology was natural: both disciplines demand the same underlying skill: designing systems that are coherent, usable, and resilient under pressure.
At GoldWhite, Jonas applies this combination of large-scale operational experience, product and UX thinking, and AI fluency to help startups and growing businesses build the infrastructure they need to scale. He also integrates AI, including agentic workflow systems, into operational and product design, helping clients identify where intelligent automation can accelerate execution and reduce friction across their business.
At GoldWhite, Jonas has contributed to raising over £6M for clients, led the creation of pitch materials, and provides management consulting on strategy, project planning, and milestone setting.